Twelve-month follow-up results of photoselective vaporization of the prostate with a 980-nm diode laser for treatment of benign hyperplasia

Korean Journal of Urology

Volumn 54, Issue 10, 2013, Pages 677-681

  Kim, Youngho ^a   Seong, Youl Keun ^a   Kim, In Gon ^a   Han, Bo Hyun ^a  

^a Maryknoll Hospital   (South Korea)

Author keywords

Benign prostatic hyperplasia; Complications; K2 diode; Laser

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK; CYSTOSCOPE; DIGITAL RECTAL EXAMINATION; DIODE LASER; DYSURIA; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; POSTVOID RESIDUAL URINE VOLUME; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE VOLUME; QUALITY OF LIFE INDEX; RESECTOSCOPE; RETROSPECTIVE STUDY; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL ELECTROVAPORIZATION; TREATMENT OUTCOME; URETHRA STRICTURE; URETHRAL CATHETERIZATION; URETHROTOMY; URGE INCONTINENCE; URINE FLOW RATE; UROFLOWMETRY;

EID: 84886287405     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2013.54.10.677     Document Type: Article

References (29)

1. Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 2008;180:241-5.
2. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999;83:227-37.
3. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004; 46:547-54.
4. Kuntz RM. Laser treatment of benign prostatic hyperplasia. World J Urol 2007;25:241-7.
5. Seitz M, Sroka R, Gratzke C, Schlenker B, Steinbrecher V, Khoder W, et al. The diode laser: a novel side-firing approach for laser va-porisation of the human prostate: immediate efficacy and 1-year follow-up. Eur Urol 2007;52:1717-22.
6. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172(4 Pt 1):1404-8.
7. Bachmann A, Schurch L, Ruszat R, Wyler SF, Seifert HH, Muller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-71.
8. Spaliviero M, Araki M, Page JB, Wong C. Catheter-free 120W lith-ium triborate (LBO) laser photoselective vaporization prostatec-tomy (PVP) for benign prostatic hyperplasia (BPH). Lasers Surg Med 2008;40:529-34.
9. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132: 474-9.
10. Levy A, Samraj GP. Benign prostatic hyperplasia: when to 'watch and wait,' when and how to treat. Cleve Clin J Med 2007;74 Suppl 3:S15-20.
11. Sarica K, Alkan E, Luleci H, Tasci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 2005;19:1199-202.
12. Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray K, et al. Short term outcomes of high power (80 W) potassium-ti-tanyl-phosphate laser vaporization of the prostate. Eur Urol 2005;48:608-13.
13. Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, et al. Photoselective KTP laser vaporization of the prostate: first ex-periences with 65 procedures. J Endourol 2004;18:976-81.
14. Malek RS. GreenLight HPS Laser Therapy for BPH: Clinical Outcomes and Surgical Recommendations from the Internatio-nal GreenLight User (IGLU) Group. EUR Urol Suppl 2008;7: 361-2.
15. Woo H, Reich O, Bachmann A, Choi B, Collins E, de la Rosette J et al. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (≥80 ml). Eur Urol Suppl 2008;7:378-83.
16. Choi B, Tabatabaei S, Bachmann A, Collins E, de la Rosette J, Gomez Sancha F et al. GreenLight HPS 120-W laser for benign prostatic hyperplasia: comparative complications and technical recommendations. EUR Urol Suppl 2008;7:384-92.
17. Cecchetti W, Guazzieri S, Tasca A, Dal Bianco M, Zattoni F, Pagano F. 980 nm diode laser and fiber optic resectoscope in en-dourological surgery. In: Laffitte F, Hibst R, Reidenbach HD, Geschwind HJ, Maira G, Pini R, et al. Laser applications in medi-cine and dentistry. Proceedings of SPIE; 1996 Sep 7; Vienna Austria. 1996;2922:291-4.
18. Kang SH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, et al. Long-term follow-up results of photoselective vaporization of the prostate with the 120 W greenlight HPS laser for treatment of be-nign prostatic hyperplasia. Korean J Urol 2011;52:260-4.
19. Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of the prostate: a size-independent new gold standard. Urology 2005;66(5 Suppl):108-13.
20. Gilling PJ, Aho TF, Frampton CM, King CJ, Fraundorfer MR. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol 2008;53:744-9.
21. Seitz M, Ackermann A, Gratzke C, Schlenker B, Ruszat R, Bachmann A, et al. Diode laser. Ex vivo studies on vaporization and coagulation characteristics. Urologe A 2007;46:1242-7.
22. Ruszat R, Wyler S, Rieken M, Seitz M, Reich O, Sroka R, et al. Prospective single-centre comparison of 120 watt photo selective vaporization of the prostate and 200 watt high-intensive diode la-ser ablation of the prostate. EUR Urol Suppl 2008;7:203.
23. Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, et al. 980-nm Diode laser: a novel laser technology for vapor-ization of the prostate. Eur Urol 2007;52:1723-8.
24. Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol 2009;182:1078-82.
25. Ruszat R, Seitz M, Wyler SF, Muller G, Rieken M, Bonkat G, et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the pros-tate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 2009;104: 820-5.
26. Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C, et al. Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci 2009;24:419-24.
27. Seitz M, Bayer T, Ruszat R, Tilki D, Bachmann A, Gratzke C, et al. Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations. BJU Int 2009; 103:770-5.
28. Seitz M, Reich O, Gratzke C, Schlenker B, Karl A, Bader M, et al. High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci 2009;24:172-8.
29. Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, et al. Comparison of potassium-titanyl-phosphate laser vapor-ization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int 2008;102:1432-8.